Diagnostic and Therapeutic Applications of Recombinant Antibodies:Targeting the Extra-Domain B of Fibronectin, A Marker of Tumor Angiogenesis

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|10|13|1537-1549

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.10, Iss.13, 2004-05, pp. : 1537-1549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract